Kcl/d5w/nacl .15/.45% Inj, 1000ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered as an infusion into a vein over a period of time. Your doctor may instruct you on how to self-administer this medication.
Before and after handling the medication, wash your hands thoroughly. Do not use the medication if the solution appears cloudy, is leaking, or contains particles. Additionally, do not use the solution if it has changed color.
To dispose of used needles and other sharp objects, use a needle/sharp disposal box. Never reuse needles or other items. When the disposal box is full, follow local regulations for proper disposal. If you have any questions or concerns, consult your doctor or pharmacist.
Storage and Disposal
Typically, this medication is administered in a hospital or doctor's office. If you need to store it at home, follow the storage instructions provided by your doctor.
Missed Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Report any discomfort or pain at the IV site immediately.
- Inform your healthcare provider about any new or worsening symptoms, such as shortness of breath, swelling, or changes in urination.
- Follow all instructions regarding fluid intake or restrictions if advised by your doctor.
Available Forms & Alternatives
Available Strengths:
- Potassium Cl 2meq/ml Inj 30ml
- Kcl/d5w/nacl 0.15/0.9 Inj , 1000ml
- Kcl/d5w/nacl .15/.45% Inj, 1000ml
- Potassium Cl 2meq/ml Inj 20ml
- Potassium Cl 2meq/ml Inj 10ml
- Potassium Cl 2meq/ml Inj 20ml
- Pot Chl/nacl 0.15/.45% Inj, 1000ml
- Kcl/d5w/lr 0.15% Inj, 1000ml
- Pot Chloride 20meq Inj, 100ml
- Kcl/d5w/nacl 0.3/0.45 Inj, 1000ml
- Kcl/d5w/nacl .075/.45 Inj, 1000ml
- Kcl/d5w/nacl 0.15/0.2 Inj, 1000ml
- Pot Chl/dextrose 5%/nacl0.45% Inj
- Potassium Chloride ER 8meq Tablets
- Potassium Cl 10meq ER Tablets
- Potassium Chloride ER 8meq ER Tabs
- Potassium Cl 10meq ER Capsules
- Potassium Chlor 10% Liq(20meq/15ml)
- Potassium Chlor 20% Liq(40meq/15ml)
- Potassium Cl Micro 10meq ER Tabs
- Pot Chloride 8meq CR Capsules
- Potassium Chloride 20meq Powder Pkt
- Potassium Cl Micro 10meq ER Tabs
- Potassium Cit ER 1620mg (15meq) Tab
- Potassium Cl Micro 10meq ER Tabs
- Potassium Chl 40meq Inj, 100ml
- Potassium Chloride 10meq Inj, 50ml
- Potassium Chloride 20meq Inj, 50ml
- Potassium Chloride 10meq ER Tablets
- Kcl/d5w/lact 20meq/l Inj, 1000ml
- Potassium Chloride 20meq ER Tablets
- Potassium Cl 20meq ER Tablets
- Potassium Chloride 20meqpowder Pkt
- Potassium Cl 2meq/ml Inj 250ml
- Potassium Cl 2meq/ml Inj 50ml
- Potassium Chl 10meq Inj,100ml
- Pot Chl/nacl 40meq/l Inj, 1000ml
- Pot Chl/d5w 20meq/l Inj, 1000ml
- Pot Chl/d5w 10meq/l Inj, 1000ml
- Potassium Chlor/nacl 20meq/l Inj
- Potassium Chloride 15meq ER Tabs
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of fluid and electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or fainting
+ Increased thirst
+ Seizures
+ Feeling extremely tired or weak
+ Decreased appetite
+ Unable to pass urine or changes in urine production
+ Dry mouth
+ Dry eyes
+ Severe stomach upset or vomiting
Signs of skin infection, such as:
+ Oozing
+ Heat
+ Swelling
+ Redness
+ Pain
Swelling, warmth, numbness, color changes, or pain in a leg or arm
Chest pain or pressure
Fever
Shortness of breath
Sudden weight gain
Swelling in the arms or legs
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor for guidance:
Irritation or swelling at the injection site
* Pain at the injection site
This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Shortness of breath or difficulty breathing
- Swelling in your ankles, feet, or hands
- Rapid weight gain
- Increased thirst or dry mouth
- Muscle weakness or cramps
- Irregular heartbeat
- Confusion or dizziness
- Headache
- Nausea or vomiting
- Pain, redness, or swelling at the IV site
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that this medication can be taken with all your current medications and health conditions. Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor.
Precautions & Cautions
If your medication contains potassium, consult your doctor before using any salt substitutes or products that also contain potassium.
If your medication contains dextrose and you have diabetes (high blood sugar), discuss this with your doctor to ensure safe management of your condition.
Regular blood tests will be necessary as directed by your doctor. Be sure to follow their instructions and discuss any concerns or questions you may have.
When administering this medication to newborns, exercise caution due to a potentially higher risk of side effects in this age group.
If you are pregnant, planning to become pregnant, or are breastfeeding, notify your doctor. They will help you weigh the benefits and risks of this medication to both you and your baby, ensuring an informed decision.
Overdose Information
Overdose Symptoms:
- Fluid overload (e.g., pulmonary edema, peripheral edema, hypertension, heart failure)
- Severe hyperkalemia (e.g., muscle weakness, paralysis, cardiac arrhythmias, cardiac arrest)
- Severe hypernatremia (e.g., thirst, lethargy, confusion, seizures, coma)
- Hyperglycemia (e.g., polyuria, polydipsia, dehydration, diabetic ketoacidosis in susceptible patients)
What to Do:
Immediate medical attention is required. Management involves discontinuing the infusion, administering diuretics for fluid overload, administering insulin and glucose for hyperkalemia, and other supportive measures as indicated by specific electrolyte imbalances. Call 911 or Poison Control (1-800-222-1222).
Drug Interactions
Contraindicated Interactions
- Patients with known hypersensitivity to any component (e.g., corn products for dextrose).
- Patients with severe hyperkalemia.
- Patients with severe hypernatremia.
- Patients with severe fluid overload or pulmonary edema.
- Patients with anuria or severe oliguria (unless on dialysis).
Major Interactions
- Drugs that increase potassium levels (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs, cyclosporine, tacrolimus) - increased risk of hyperkalemia.
- Corticosteroids or other sodium-retaining drugs - increased risk of hypernatremia and fluid retention.
- Insulin (large doses) - may cause rapid shift of potassium into cells, leading to hypokalemia (though dextrose in solution may counteract this to some extent).
- Digoxin - potassium imbalances (hypo- or hyperkalemia) can alter digoxin toxicity.
Moderate Interactions
- Diuretics (loop or thiazide) - may alter sodium and potassium balance, requiring careful monitoring.
- Lithium - sodium levels can affect lithium excretion; changes in sodium intake/administration may alter lithium levels.
Minor Interactions
- None commonly cited for direct interaction with this specific IV fluid combination, but general caution with any medication affecting fluid or electrolyte balance.
Monitoring
Baseline Monitoring
Rationale: To establish baseline electrolyte status and identify pre-existing imbalances.
Timing: Prior to initiation of therapy
Rationale: To assess kidney's ability to excrete electrolytes and fluid.
Timing: Prior to initiation of therapy
Rationale: To assess hydration status and risk of fluid overload.
Timing: Prior to initiation of therapy
Rationale: To establish baseline glucose level, especially in diabetic patients.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Every 4-24 hours, depending on clinical status and infusion rate
Target: Sodium: 135-145 mEq/L; Potassium: 3.5-5.0 mEq/L; Chloride: 98-106 mEq/L
Action Threshold: Values outside normal range, especially critical values (e.g., K < 3.0 or > 5.5 mEq/L, Na < 130 or > 150 mEq/L) require immediate intervention.
Frequency: Every 8-24 hours (I&O), Daily (Weight)
Target: Balanced I&O, stable weight or desired change.
Action Threshold: Significant positive or negative fluid balance, rapid weight gain/loss, or signs of fluid overload/dehydration.
Frequency: Every 4-6 hours, especially in diabetic or critically ill patients
Target: 70-180 mg/dL (target may vary based on patient condition)
Action Threshold: Hypoglycemia (<70 mg/dL) or hyperglycemia (>180-200 mg/dL).
Frequency: Every 4-8 hours or more frequently as clinically indicated
Target: Within patient's normal limits
Action Threshold: Changes indicative of fluid overload (e.g., elevated BP, crackles) or dehydration (e.g., tachycardia, hypotension).
Symptom Monitoring
- Signs of fluid overload (e.g., dyspnea, crackles, peripheral edema, jugular venous distension)
- Signs of hyperkalemia (e.g., muscle weakness, paresthesias, cardiac arrhythmias)
- Signs of hypokalemia (e.g., muscle weakness, cramps, fatigue, cardiac arrhythmias)
- Signs of hypernatremia (e.g., thirst, lethargy, confusion, seizures)
- Signs of hyponatremia (e.g., headache, nausea, confusion, seizures)
- Signs of hyperglycemia (e.g., polyuria, polydipsia, fatigue)
- Signs of hypoglycemia (e.g., sweating, tremors, dizziness, confusion)
- Local site reactions (e.g., pain, redness, swelling at infusion site)
Special Patient Groups
Pregnancy
Generally considered safe when clinically indicated for fluid and electrolyte replacement. Close monitoring of fluid and electrolyte balance is crucial to avoid complications for both mother and fetus.
Trimester-Specific Risks:
Lactation
Components are endogenous and generally considered compatible with breastfeeding when administered appropriately. No known adverse effects on the breastfed infant.
Pediatric Use
Use with extreme caution and precise calculation of fluid and electrolyte needs based on weight, age, and clinical condition. Pediatric patients are more susceptible to fluid overload, electrolyte imbalances (especially hyponatremia and hyperkalemia), and glucose abnormalities. Frequent monitoring of fluid balance, electrolytes, and blood glucose is essential.
Geriatric Use
Use with caution due to increased risk of fluid overload, electrolyte imbalances (especially hypernatremia and hyperkalemia due to age-related decline in renal function), and cardiovascular compromise. Start with lower infusion rates and monitor fluid status, electrolytes, and renal function closely.
Clinical Information
Clinical Pearls
- Always verify the correct solution, concentration, and infusion rate before administration to prevent medication errors.
- Assess patient's fluid status (skin turgor, mucous membranes, I&O, daily weight, vital signs) and electrolyte levels frequently.
- Be vigilant for signs of fluid overload (e.g., crackles, dyspnea, edema) or electrolyte imbalances (e.g., cardiac arrhythmias, muscle weakness).
- Ensure adequate renal function before administering potassium-containing solutions to prevent hyperkalemia.
- Avoid rapid infusion, especially in patients at risk for fluid overload or electrolyte shifts.
- This solution provides minimal calories; consider additional nutritional support for prolonged therapy.
Alternative Therapies
- Oral rehydration solutions (for mild dehydration/electrolyte imbalance)
- Specific electrolyte supplements (e.g., oral potassium chloride for hypokalemia)
- Total Parenteral Nutrition (TPN) for comprehensive nutritional support.